Conference Proceedings

Pregnancy protects against long-term disability accrual in relapsing-remitting MS

VG Jokubaitis, T Kalincik, J Lorscheider, T Spelman, D Horakova, P Duquette, M Girard, A Prat, G Izquierdo, P Grammond, E Pucci, F Grand'Maison, F Granella, P Sola, R Bergamaschi, G Iuliano, D Spitaleri, S Hodgkinson, J Olascoaga, F Verheul Show all



Awarded by NHMRC

Awarded by NHMRC Centre for Research Excellence Grant

Funding Acknowledgements

This investigator-initiated analysis was supported by a project grant from the NHMRC Project Grant [Grant ID 1032484], and an NHMRC Centre for Research Excellence Grant [Grant ID 1001216].TK served on scientific advisory boards for Novartis, Merck and Biogen, has received conference travel support and/or speaker honoraria from Novartis, Biogen, Sanofi, Genzyme, Teva and Merck and has received research support from Biogen.DH received speaker honoraria and consulting fees from Biogen, Merck Serono, Teva and Novartis, as well as support for research activities from Biogen.PD served on editorial boards and has been supported to attend meetings by EMDSerono, Biogen, Novartis, Genzyme, and TEVA Neuroscience. He has received funding for investigator-initiated trials from Biogen, Novartis, and Genzyme.MG received consulting fees from Teva Canada Innovation, Biogen, Novartis and Genzyme Sanofi; lecture payments from Teva Canada Innovation, Novartis and EMD Serono.PG is a Novartis, Teva-neuroscience, Biogen and Genzyme advisory board member, consultant for Merck Serono, received payments for lectures by Merck Serono, Teva-Neuroscience, and received grants for travel from Teva-Neuroscience and Novartis. EP served on scientific advisory boards for Merck Serono, Genzyme and Biogen; he has received honoraria and travel grants from Sanofi, Novartis, Bayer Schering, Biogen, Merck Serono, Genzyme and Teva.FGM received honoraria or research funding from Biogen, Genzyme, Novartis, and Teva Neurosciences.FG served on scientific advisory boards for Biogen Idec, Novartis and Sanofi and received funding for travel and speaker honoraria from Biogen Idec and Merck Serono.PS received travel grants and speaking honoraria from Bayer Schering, Biogen, Merck Serono, Novartis, Sanofi/Genzyme and Teva.AL is a Bayer, Biogen, Genzyme, Merck Advisory Board Member. She received travel grants and honoraria from Bayer, Biogen, Merck, Novartis, Sanofi, and Teva. Her institution received research grants from Bayer, Biogen, Merck, Novartis, Sanofi, and Teva.MT received speaker honoraria from Biogen-Idec, Bayer-Schering, Sanofi, Merck-Serono, Teva, and Novartis; has received research grants for her Institution from Biogen-Idec, Merck-Serono, and Novartis.We would also like to acknowledge the MSBase Foundation for its support of this project. The MSBase Foundation is an independent not for profit organisation which receives support in the form of grants from the National Health and Medical Research Council (NHMRC) Australia, Merck, Merck Serono, Biogen, Novartis, and Genzyme a Sanofi company.